Communiqués Humanigen, Inc.

Actions

HGENQ

US4448632038

Temps Différé OTC Markets Autres places de cotation 15:31:56 04/06/2024			Varia. 5j.	Varia. 1 janv.
0,0001 ^USD	+9 900,00 %		-66,67 %	-91,67 %

01/05	Audience combinée pour l'approbation de la déclaration d'information et du plan pour Humanigen, Inc.	CI
05/01	Humanigen, concepteur du traitement COVID-19, se place sous la protection du chapitre 11 de la loi sur les faillites	RE

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

CapitalGainesReport: OTC Bounce List (EPAZ, ABML, HGEN, RINO)	09/08/23	AQ
Exploring Breakthrough Biotech Stocks: ENZC, CYDY, HGEN, HALB	19/07/23	AQ
HUMANIGEN, INC : Other Events, Financial Statements and Exhibits (form 8-K)	19/04/23	AQ
HUMANIGEN, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	06/04/23	AQ
HUMANIGEN, INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	30/03/23	AQ
HUMANIGEN, INC : Regulation FD Disclosure (form 8-K)	13/03/23	AQ
HUMANIGEN, INC : Other Events, Financial Statements and Exhibits (form 8-K)	02/03/23	AQ
HUMANIGEN, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits (form 8-K)	24/02/23	AQ
HUMANIGEN, INC : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	22/12/22	AQ
HUMANIGEN, INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	14/11/22	AQ
HUMANIGEN, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	06/10/22	AQ
HUMANIGEN, INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	29/09/22	AQ
HUMANIGEN, INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	02/09/22	AQ
HUMANIGEN, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	26/08/22	AQ
Humanigen : Reports Second Quarter 2022 Financial Results - Form 8-K	12/08/22	PU
HUMANIGEN, INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	12/08/22	AQ
Humanigen Reports Second Quarter 2022 Financial Results	12/08/22	BU
HUMANIGEN, INC : Termination of a Material Definitive Agreement, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	26/07/22	AQ
Humanigen : receives preliminary topline data from NIH/NIAID study of lenzilumab in ACTIV-5/BET-B - Form 8-K	13/07/22	PU
HUMANIGEN, INC : Other Events, Financial Statements and Exhibits (form 8-K)	13/07/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Humanigen, Inc.

Actions

HGENQ

US4448632038

Communiqués

Filtres